<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Recent studies showed that soluble annexin A2 dramatically increases tissue plasminogen activator (tPA)-mediated plasmin generation in vitro, and reduces <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation in vivo </plain></SENT>
<SENT sid="1" pm="."><plain>Here, we hypothesize that combining annexin A2 with tPA can significantly enhance thrombolysis efficacy, so that lower doses of tPA can be applied in <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> to avoid neurotoxic and hemorrhagic complications </plain></SENT>
<SENT sid="2" pm="."><plain>In vitro activity assays confirmed tPA-specific amplification of plasmin generation by recombinant annexin A2 </plain></SENT>
<SENT sid="3" pm="."><plain>In a rat focal embolic <z:hpo ids='HP_0001297'>stroke</z:hpo> model, combination therapy with tPA and recombinant annexin A2 protein at 2 h post-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> decreased the effective dose required for tPA by four-fold and reduced <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Combining annexin A2 with tPA also lengthened the time window for thrombolysis </plain></SENT>
<SENT sid="5" pm="."><plain>Compared with tPA (10 mg/kg) alone, the combination of annexin A2 (5 mg/kg) plus low-dose tPA (2.5 mg/kg) significantly enhanced fibrinolysis, attenuated mortality, <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e>, and hemorrhagic transformation, even when administered at 4 h post-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Combination with recombinant annexin A2, the effective thrombolytic dose of tPA can be decreased </plain></SENT>
<SENT sid="7" pm="."><plain>As a result, brain <z:mp ids='MP_0001914'>hemorrhage</z:mp> and infarction are reduced, and the time window for <z:hpo ids='HP_0001297'>stroke</z:hpo> reperfusion prolonged </plain></SENT>
<SENT sid="8" pm="."><plain>Our present findings provide a promising new approach for enhancing tPA-based thrombolytic <z:hpo ids='HP_0001297'>stroke</z:hpo> therapy </plain></SENT>
</text></document>